FIDIS™ Vasculitis Panel - NEW
The BMD FIDIS™ Vasculitis Panel utilises the Luminex® xMAP technology to simultaneously detect ANCA-MPO, ANCA-PR3 and GBM autoantibodies in a patient sample with only one assay procedure.
The FIDIS™ is now in routine use in Australia and New Zealand. The Vasculitis Panel is the newest addition to the range of FIDIS autoimmune panels, and has already shown excellent performance in recent correlation studies. Contact Diagnostic Solutions for more information.
- Fully automated using the BMD CARIS™ front-end pipetting system
- Fast turnaround of results
- 30:30 incubation times
- <30 secs per sample reading time using the FIDIS™ Luminex® system
- Bi-directional LIS interface
- enabling only requested tests to be reported
- On-board Levey-Jennings QC monitoring
Other FIDIS™ Panels
BMD have extensive range of Autoimmune Panels now available using the FIDIS™ system. They include the following;
-
Connective 10 Panel: simultaneous detection of antibodies to dsDNA, Centromere and 8 ENA autoantibodies.
Learn more
-
Celiac IgA Panel: simultaneous detection of IgA antibodies to tTG and Gliadin.
Learn more
-
Celiac IgG Panel: simultaneous detection of IgG antibodies to tTG and Gliadin.
Learn more
-
Thyroid Panel: simultaneous detection of antibodies to TPO and Thyroglobulin (a-TG).
Learn more
-
Rheuma Panel: simultaneous detection of IgM antibodies to Human and Animal Rheumatoid Factor.
Learn more
-
Cytokine Panels: there are now a large range of human cytokine panels also available using the FIDIS™ System.
Learn More
Vasculitis Quality Control (QC)
Diagnostic Solutions has
QC material available for use by ELISA or FIDIS™ methodologies.
Learn more
Back to TOP